Results 111 to 120 of about 346 (139)

Lipoma arborescens; successfully treated by yttrium-90 radiosynovectomy

Annals of Nuclear Medicine, 2003
Although radiosynovectomy (RS) applications have been carried out for many years, clinical indications of this non-invasive procedure is thought to be limited probably due to the lack of information of clinicians. Clinicians' preferential indication for RS is the treatment-resistant synovitis of individual joints, i.e.
Erselcan T., Bulut O., Bulut S., Dogan D., Turgut B., Ozdemir S., Goze F.   +6 more
openaire   +5 more sources

[Radiosynovectomy with dysprosium-165 iron hydroxide].

Acta medica Austriaca, 1993
Treatment of chronic rheumatoid synovitis (RS) is directed to control the inflammatory process causing pain and disability. Radiation synovectomy is suggested to be an alternative to surgical treatment, but its clinical use has been restricted because of significant leakage (> 10%) associated with the use of the standard radionuclide 90-Yttrium (used ...
C, Pirich, A, Wanivenhaus, W, Graninger, H, Kvaternik, P, Angelberger, B, Pesau, E, Havlik, J, Flores, H, Sinzinger   +8 more
openaire   +2 more sources

Radiosynovectomy's clinical applications and cost effectiveness: A review

Seminars in Nuclear Medicine, 1997
It is apparent that from the work of the authors and many others, including the work of Rivard, Sledge, Zuckerman, among others, that radiosynovectomy has an important role to play in providing effective treatment of affected joints associated with rheumatoid arthritis and other forms of arthritis as well as the hemophiliac joint.
M E, Siegel, H J, Siegel, J V, Luck
openaire   +2 more sources

Radiosynovectomy in Children with Congenital Haemostatic Defects

Blood, 2008
Abstract Aims: To evaluate the clinical benefits of radiosynovectomy (RS) in children with congenital coagulative disorders, reduce bleeds and improve progression free survival (PFS). Methods: 35 patients aged 7 to 17 yrs, (mean age 12.6 yrs) were included in the study. 29 had haemophilia A, (4 with inhibitor factor VIII),
Michal Matysiak, Jan Walecki, Anna Klukowska, Jaroslaw Cwikla, Piotr Zbikowski, Pawel PL Laguna   +5 more
openaire   +1 more source

Radiosynovectomy: Science and Practice

2012
While for the majority of the patients, rheumatoid and other arthritis can be controlled satisfactorily, long-term systemic therapy fails in some cases and not only its side effects accumulate to a serious level. Radiosynovectomy should be used timely after long-term systemic pharmacotherapy or intra-articular steroid injections have failed. The method
openaire   +1 more source

Phosphate-32 Colloid Radiosynovectomy in Hemophilia

Clinical Orthopaedics and Related Research, 2001
Radiosynovectomy offers a potentially effective, minimally invasive option for patients with chronic hemarthrosis and synovitis. The long-term outcome of patients with hemophilia who were treated with phosphate-32 chromic phosphate radiosynovectomy was evaluated. One hundred twenty-five procedures in 81 patients were done.
H J, Siegel, J V, Luck, M E, Siegel, C, Quinones   +3 more
openaire   +2 more sources

Opinions on radiosynovectomy for chronic haemophilic synovitis: point/counterpoint

Haemophilia, 2012
SummaryJoint bleeding is the hallmark of severe haemophilia and the major cause of disability in patients with this coagulopathy. Repeated bleeding into the same joint can lead to chronic synovitis and progressive arthropathy. Radiosynovectomy is one option for the treatment of chronic haemophilic synovitis, but concerns about the risks of exposure to ...
M, Silva, J V, Luck, C, Leissinger
openaire   +2 more sources

Multivariate analysis of factors influencing the effect of radiosynovectomy

Nuklearmedizin, 2002
Summary Objective: In this prospective study, the time to remission after Radiosynovectomy (RSV) was analyzed and the influence of age, sex, underlying disease, type of joint, and duration of illness on the success rate of RSV was determined. Methods: A total number of 57 patients with rheumatoid arthritis (n = 33) and arthrosis (n = 21) with
J, Farahati, G, Schulz, J, Wendler, C, Körber, M, Geling, W, Kenn, P, Schmeider, C, Reidemeister, Chr, Reiners   +8 more
openaire   +2 more sources

Preparation of 188Re-labeled hydroxyapatite for radiosynovectomy

Journal of Radioanalytical and Nuclear Chemistry, 2002
Hydroxyapatite (HA), a natural constituent of bone, was synthesized. HA particles were radiolabeled with 188Re. Radiolabeling efficiency was 95%. In vitro studies showed 5% loss of activity from particles in normal saline over a period of 2 days, whereas a dissociation rate of 9% was observed in human serum albumin.
S. Pervez, A. Mushtaq, M. Arif
openaire   +1 more source

Radiosynovectomy in rheumatology, orthopedics, and hemophilia.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2005
Radiosynovectomy (RSV) is a local intraarticular injection of radionuclides in colloidal form for radiotherapy. First used by Fellinger et al. in 1952, the technique has now been applied for more than 50 y for treatment of resistant synovitis of individual joints after failure of long-term systemic pharmacotherapy and intraarticular steroid injections.
Peter, Schneider, Jamshid, Farahati, Christoph, Reiners   +2 more
openaire   +1 more source